RYTM · Rhythm Pharmaceuticals, Inc.
$115.48
-0.54 (-0.47%)
At close · Aug 14
Market Cap
$7.95B
Shares
68.85M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| David Meeker | Chief Executive Officer | $17,544,525 |
| Hunter Smith | Chief Financial Officer | $6,228,429 |
| Yann Mazabraud | Executive Vice President, Head of International | $6,118,455 |
| Jennifer Lee | Executive Vice President, Head of North America | $5,602,816 |
| Alastair Garfield | Chief Scientific Officer | $4,427,024 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| David Meeker | Chief Executive Officer | $14,663,742 |
| Yann Mazabraud | Executive Vice President, Head of International | $5,095,270 |
| Hunter Smith | Chief Financial Officer | $5,050,410 |
| Jennifer Lee | Executive Vice President, Head of North America | $4,318,212 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| David Meeker | Chief Executive Officer | $7,230,457 |
| Hunter Smith | Chief Financial Officer | $2,308,007 |
| Jennifer Lee | Executive Vice President, Head of North America | $2,106,210 |
| Yann Mazabraud | Executive Vice President, Head of International | $1,742,009 |
| Joseph Shulman | Chief Technical Officer | $1,740,468 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| David Meeker | Chief Executive Officer | $3,325,758 |
| Hunter Smith | Chief Financial Officer | $1,215,125 |
| Yann Mazabraud | Executive Vice President, Head of International | $1,189,905 |
| Jennifer Lee | Executive Vice President, Head of North America | $1,086,675 |
| Jennifer Chien | Executive Vice President, Head of North America | $1,086,675 |
| Joseph Shulman | Chief Technical Officer | $950,113 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| David Meeker | Chief Executive Officer | $6,458,360 |
| Hunter Smith | Chief Financial Officer | $2,309,413 |
| Yann Mazabraud | Executive Vice President, Head of International | $2,177,605 |
| Jennifer Lee | Executive Vice President, Head of North America | $2,081,453 |
| Jennifer Chien | Executive Vice President, Head of North America | $2,081,452 |
| Murray Stewart | Former Chief Medical Officer | $1,990,752 |
| Joseph Shulman | Chief Technical Officer | $1,788,243 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| David Meeker | Chief Executive Officer | $14,277,367 |
| Keith M. Gottesdiener | Former President and Chief Executive Officer | $3,449,169 |
| Hunter Smith | Chief Financial Officer | $2,662,468 |
| Murray Stewart | Former Chief Medical Officer | $2,300,314 |
| Nithya Desikan | Former Chief Commercial Officer | $1,943,971 |
| Jennifer Chien | Executive Vice President, Head of North America | $1,819,617 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Keith M. Gottesdiener | Former President and Chief Executive Officer | $4,937,042 |
| Hunter Smith | Chief Financial Officer | $1,922,853 |
| Nithya Desikan | Former Chief Commercial Officer | $1,810,241 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Keith M. Gottesdiener | M.D. , Former President and Chief Executive Officer | $3,539,804 |
| Hunter Smith | Chief Financial Officer, Treasurer, Secretary and Interim President and Chief Executive Officer | $1,587,137 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Edward T. Mathers | Board | Resigned | 2026-04-03 |
| Kimberly J. Popovits | non-employee director | Appointed | 2026-04-03 |
| Camille L. Bedrosian, M.D. | Board | Resigned | 2025-12-19 |
| William T. Roberts | Chief Accounting Officer | Terminated | 2023-08-08 |
Key facts
CIK
1649904
CUSIP
76243J105
13F (30d)
283 filings
281 filers
Visit website
Investor relations